O-Methyl-N-(9-methyl-9H-purin-6-yl)-N-[(E)-3-methyl-5-((1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydro-naphthalen-1-yl)-pent-2-enyl]-hydroxylamine | 145433-78-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: O-Methyl-N-(9-methyl-9H-purin-6-yl)-N-[(E)-3-methyl-5-((1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydro-naphthalen-1-yl)-pent-2-enyl]-hydroxylamine
• 英文别名: N-[(E)-5-[(1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enyl]-N-methoxy-9-methylpurin-6-amine
• CAS: 145433-78-9
• 化学式: C₂₇H₄₁N₅O
• 分子量: 451.655
• InChiKey: YJCKIWSKLCQUJC-DSEFFAGJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  56.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N⁶-methoxy-9-methyladenine 、 (3R,4S,4aR,8aR)-4-[(E)-5-bromo-3-methylpent-3-enyl]-3,4,8,8a-tetramethyl-1,2,3,4a,5,6-hexahydronaphthalene 在 四丁基碘化铵 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 以52%的产率得到6-Methoxyamino-9-methyl-7-[(E)-3-methyl-5-((1S,2R,4aR,8aR)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydro-naphthalen-1-yl)-pent-2-enyl]-9H-purin-7-ium; bromide
  参考文献：
  名称：

  Total syntheses of the diterpenoids (−)-kolavenol and (−)-agelasine B

  摘要：

  The trans-clerodane diterpenoids (-)-kolavenol (2) and (-)-agelasine B (1) have been prepared from the enantiomerically pure decalone 3. The key steps of the syntheses involve the stereoselective alkylation of the nitrile 4 (to give 5), the efficient coupling of the iodides 10 and 11 to produce the clerodane skeleton 12, and the electrochemical reduction of 16 to provide (-)-1.

  DOI：

  10.1016/s0040-4039(00)60896-1

文献信息

• Total syntheses of the diterpenoids (−)-kolavenol and (−)-agelasine B
  作者：Edward Piers、Jacques Y. Roberge

  DOI：10.1016/s0040-4039(00)60896-1

  日期：1992.11

  The trans-clerodane diterpenoids (-)-kolavenol (2) and (-)-agelasine B (1) have been prepared from the enantiomerically pure decalone 3. The key steps of the syntheses involve the stereoselective alkylation of the nitrile 4 (to give 5), the efficient coupling of the iodides 10 and 11 to produce the clerodane skeleton 12, and the electrochemical reduction of 16 to provide (-)-1.